View Item 

Show simple item record

Natural Antioxidants for the Prevention of Atherosclerosis

dc.contributor.authorOdeh, Rudina M.en_US
dc.contributor.authorCornish, Laura A.en_US
dc.date.accessioned2012-03-16T16:01:22Z
dc.date.available2012-03-16T16:01:22Z
dc.date.issued1995-09-10en_US
dc.identifier.citationOdeh, Rudina M.; Cornish, Laura A. (1995). "Natural Antioxidants for the Prevention of Atherosclerosis." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 15(5). <http://hdl.handle.net/2027.42/90387>en_US
dc.identifier.issn0277-0008en_US
dc.identifier.issn1875-9114en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90387
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.titleNatural Antioxidants for the Prevention of Atherosclerosisen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacy Services, University of Michigan Medical Center and College of Pharmacy, Ann Arbor, Michiganen_US
dc.identifier.pmid8570438en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90387/1/j.1875-9114.1995.tb02875.x.pdf
dc.identifier.doi10.1002/j.1875-9114.1995.tb02875.xen_US
dc.identifier.sourcePharmacotherapy: The Journal of Human Pharmacology and Drug Therapyen_US
dc.identifier.citedreferenceKallner A., Hartmann D., Hornig D. On the absorption of ascorbic acid in man. Int J Vitam Nutr Res 1977; 47: 383 – 8.en_US
dc.identifier.citedreferenceSalonen JT, Salonen R., Seppanen K. et al. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in eastern Finnish men. Atherosclerosis 1988; 70: 155 – 60.en_US
dc.identifier.citedreferenceWang YX, Bocker K., Reuter H. et al. Selenium and myocardial infarction: glutathione peroxidase in platelets. Klin Wochenschr 1981; 59: 817 – 18.en_US
dc.identifier.citedreferenceOster O., Drexler M., Schenk J. et al. The serum selenium concentration of patients with acute myocardial infarction. Ann Clin Res 1986; 18: 36 – 42.en_US
dc.identifier.citedreferenceRingstad J., Thelle D. Risk of myocardial infarction in relation to serum concentrations of selenium. Acta Pharmacol Toxicol 1986; 59: 336 – 9.en_US
dc.identifier.citedreferenceAmerican Regent Laboratories, Inc. Selenium solution package insert. Shirley, NY: 1986 September.en_US
dc.identifier.citedreferenceRosenfield I., Beath DA. Selenium, geobotany, biochemistry, toxicity and nutrition. New York: Academic Press, 1964.en_US
dc.identifier.citedreferenceDiskin DJ, Tomasso CL, Alper JC et al. Long‐term selenium exposure. Arch Intern Med 1979; 139: 824 – 6.en_US
dc.identifier.citedreferenceSchrauzer GN, White DA. Selenium in human nutrition: dietary intakes and effects of supplementation. Bioinorg Chem 1978; 8: 303 – 18.en_US
dc.identifier.citedreferenceSakurai H., Tsuchiya K. A tentative recommendation for the maximum daily intake of selenium. Environ Physiol Biochem 1975; 5: 107 – 18.en_US
dc.identifier.citedreferenceChow CK, Thacker RR, Chanchit C. et al. Lower levels of vitamin C and carotenes in plasma of cigarette smokers. J Am Coll Nutr 1986; 3: 305 – 12.en_US
dc.identifier.citedreferenceBolton‐Smith C., Casey CE, Gey KF et al. Antioxidant vitamin intake assessed using a food‐frequency questionnaire: correlation with biochemical status in smokers and nonsmokers. Br J Nutr 1991; 65: 337 – 46.en_US
dc.identifier.citedreferenceHarats D., Naim BM, Dabach Y. et al. Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis 1989; 79: 245 – 52.en_US
dc.identifier.citedreferenceSteinberg D. Antioxidants in the prevention of human atherosclerosis. Circulation 1992; 85: 2337 – 44.en_US
dc.identifier.citedreferenceJacob RA. Vitamin C. In: Shils ME, Olson JA, Shike M. eds. Modern nutrition in health and disease. Philadelphia: Lea & Febiger, 1994: 432 – 48.en_US
dc.identifier.citedreferenceNational Research Council. Recommended dietary allowances, 10th ed. Washington, DC: National Academy of the Sciences, 1989.en_US
dc.identifier.citedreferenceIyengar V., Woittiez J. Trace elements in human clinical specimens: evaluation of literature data to identify reference values. Clin Chem 1988; 34: 474 – 81.en_US
dc.identifier.citedreferenceGenton RE, Sobel BE. Acute myocardial infarction in perspective. In: Messerli FH ed. Cardiovascular drug therapy. Philadelphia: WB Saunders, 1990: 2 – 8.en_US
dc.identifier.citedreferenceNational Heart, Lung, and Blood Institute. Morbidity and mortality: chartbook on cardiovascular, lung, and blood diseases. Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, 1992.en_US
dc.identifier.citedreferenceGraves EJ. 1983 summary: national hospital discharge survey. Rockville, MD: National Center for Health Statistics, 1984.en_US
dc.identifier.citedreferenceHlatky MA, Cotugno HE, Mark DB et al. Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987. Am J Cardiol 1988; 61: 515 – 18.en_US
dc.identifier.citedreferenceGonzalez ER, Sypniewski E. Acute myocardial infarction: diagnosis and treatment. In: DiPiro JT, Talbert RL, Hayes PE et al, eds. Pharmacotherapy. New York: Elsevier, 1992: 231 – 54.en_US
dc.identifier.citedreferenceGotto AM, Phil D., Farmer JA. Risk factors for coronary artery disease. In: Braunwald E. ed. Heart disease: a textbook of cardiovascular medicine. Philadelphia: WB Saunders, 1988: 1153 – 90.en_US
dc.identifier.citedreferenceNeufeld HN, Goldbourt U. Coronary heart disease: genetic aspects. Circulation 1983; 67: 943 – 7.en_US
dc.identifier.citedreferenceSteinberg D., Parthasarathy S., Carew TE et al. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915 – 24.en_US
dc.identifier.citedreferenceGoldstein JL, Ho YK, Basu SK et al. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci 1979; 76: 333 – 7.en_US
dc.identifier.citedreferenceLyons TJ. Oxidized low density lipoproteins: a role in the pathogenesis of atherosclerosis in diabetes. Diabet Med 1991; 8: 411 – 19.en_US
dc.identifier.citedreferenceWitztum JL, Steinberg D. Role of oxidized low‐density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785 – 92.en_US
dc.identifier.citedreferenceGerrity RG. The role of the monocyte in atherogenesis. I. Transition of blood‐borne monocytes into foam cells in fatty lesions. N Engl J Med 1981; 103: 181 – 90.en_US
dc.identifier.citedreferenceFogelman AM, Schechter I., Hokom M. et al. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte‐macrophages. Proc Natl Acad Sci 1980; 77: 2214 – 18.en_US
dc.identifier.citedreferenceSteinberg D. Antioxidants and atherosclerosis: a current assessment. Circulation 1991; 84: 1420 – 5.en_US
dc.identifier.citedreferenceEsterbauer H., Rotheneder M., Striegl G. Vitamin E and other lipophilic antioxidants protect LDL against oxidation. Fat Sci Technol 1989; 91: 316 – 24.en_US
dc.identifier.citedreferenceEsterbauer H., Dieber‐Rotheneder M., Striegl G. et al. Role of vitamin E in preventing the oxidation of low‐density lipoprotein. Am J Clin Nutr 1991; 53: 314S – 21.en_US
dc.identifier.citedreferenceStary HC. The evolution of human atherosclerotic lesions. West Point, PA: Merck & Co., 1993.en_US
dc.identifier.citedreferenceBrown MS, Goldstein JL. A receptor‐mediated pathway for cholesterol homeostasis. Science 1986; 232: 34 – 47.en_US
dc.identifier.citedreferenceBrown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983; 52: 223 – 61.en_US
dc.identifier.citedreferenceHenrickson T., Mahoney EM, Steinberg D. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by the receptor for acetylated low density lipoproteins. Proc Natl Acad Sci U S A 1981; 78: 6499 – 503.en_US
dc.identifier.citedreferenceHenrickson T., Mahoney EM, Steinberg D. Interactions of plasma lipoproteins with endothelial cells. Ann NY Acad Sci 1982; 401: 102 – 16.en_US
dc.identifier.citedreferenceHenrickson T., Mahoney EM, Steinberg D. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis 1983; 3: 149 – 59.en_US
dc.identifier.citedreferenceMorel DW, DiCorleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984; 4: 357 – 64.en_US
dc.identifier.citedreferenceSteinbrecher UP, Parthasarathy S., Leake DS et al. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984; 83: 3883 – 7.en_US
dc.identifier.citedreferenceQuinn MT, Parthasarathy S., Fong LG et al. Endothelial cell‐derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. Proc Natl Acad Sci U S A 1985; 82: 5949 – 53.en_US
dc.identifier.citedreferenceRajavashisth TB, Andalibi A., Territo MC et al. Induction of endothelial cell expression of granulocyte and macrophage colony‐stimulating factors by modified low‐density lipoproteins. Nature 1990; 344: 254 – 7.en_US
dc.identifier.citedreferenceYoshimura T., Robinson EA, Tanaka S. et al. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin‐stimulated human peripheral blood mononuclear leukocytes. J Immunol 1989; 142: 1956 – 62.en_US
dc.identifier.citedreferenceKugiyama K., Kerns SA, Morrisett JD et al. Impairment of endothelium‐dependent arterial relaxation by lysolecithin in modified low density lipoprotein. Nature 1990; 344: 160 – 2.en_US
dc.identifier.citedreferenceKita T., Nagano Y., Yokode M. et al. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 1987; 84: 5928 – 31.en_US
dc.identifier.citedreferenceCarew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage‐rich fatty streaks slowing the progression of atherosclerosis in the WHHL rabbit. Proc Natl Acad Sci U S A 1987; 84: 7725 – 9.en_US
dc.identifier.citedreferenceSteinberg D., Carew TE, Parthasarthy S. In vivo inhibition of foam cell development by probucol in Watanabe rabbits. Am J Cardiol 1988; 62: 6B – 12.en_US
dc.identifier.citedreferenceMatsuzawa Y., Shizuya Y., Funahashi T. et al. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 choles‐terolemia with abnormal cholesteryl ester transfer. Am J Cardiol 1988; 62: 66B – 72.en_US
dc.identifier.citedreferenceGoldberg RB. Probucol enhances cholesterol efflux from cultured human skin fibroblasts. Am J Cardiol 1988; 62: 57B – 9.en_US
dc.identifier.citedreferenceSirtori CR. Changes in high‐density lipoprotein subfraction distribution and increased cholesteryl ester transfer after probucol. Am J Cardiol 1988; 62: 73B – 6.en_US
dc.identifier.citedreferenceJialal I., Fuller CJ. Oxidized LDL and antioxidants. Clin Cardiol 1993; 16 ( suppl ): I6 – 9.en_US
dc.identifier.citedreferenceEsterbauer H., Puhl H., Dieber‐Rotheneder M. et al. Effect of antioxidants on oxidative modification of LDL. Ann Intern Med 1991; 23: 573 – 81.en_US
dc.identifier.citedreferenceEsterbauer H., Jurgens G., Quehenberger O. et al. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res 1987; 28: 495 – 509.en_US
dc.identifier.citedreferenceEsterbauer H., Striegl G., Puhl H. et al. The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins. Ann NY Acad Sci 1989; 570: 254 – 67.en_US
dc.identifier.citedreferenceBurton GW, Traber MG. Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu Rev Nutr 1990; 10: 357 – 82.en_US
dc.identifier.citedreferenceEsterbauer H., Striegl G., Puhl H. et al. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Comm 1989; 6: 67 – 75.en_US
dc.identifier.citedreferenceJialal I., Grundy SM. In vivo alpha‐tocopherol supplementation inhibits LDL oxidation. Circulation 1991; 84: 1178.en_US
dc.identifier.citedreferenceGey KF, Puska P. Plasma vitamins E and A inversely related to mortality from ischemic heart disease in cross‐cultural epidemiology. Ann NY Acad Sci 1989; 570: 268 – 82.en_US
dc.identifier.citedreferenceGey F., Puska P., Jordan P. et al. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross‐cultural epidemiology. Am J Clin Nutr 1991; 53 ( suppl ): 326S – 4.en_US
dc.identifier.citedreferenceBolton‐Smith C., Woodward M., Tunstall‐Pedoe H. The Scottish heart health study: dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk I. The macronutrients. Eur J Clin Nutr 1992; 46: 75 – 84.en_US
dc.identifier.citedreferenceBolton‐Smith C., Woodward M., Tunstall‐Pedoe H. The Scottish heart health study: dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk. II. The antioxidant vitamins and fiber. Eur J Clin Nutr 1992; 46: 85 – 93.en_US
dc.identifier.citedreferenceStampfer MJ, Hennekens CH, Manson JE et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444 – 9.en_US
dc.identifier.citedreferenceRimm EB, Stampfer MJ, Ascherio A. et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450 – 6.en_US
dc.identifier.citedreferenceKok FJ, de Bruijn AM, Vermeeren R. et al. Serum selenium, vitamin anti‐oxidants and cardiovascular mortality: a 9‐year follow‐up study in the Netherlands. Am J Clin Nutr 1987; 45: 462 – 8.en_US
dc.identifier.citedreferenceSalonen JT, Salonen R., Penttilae R. et al. Serum fatty acids, apolipoproteins, selenium and vitamin anti‐oxidants and the risk of death from coronary artery disease. Am J Cardiol 1985; 56: 226 – 31.en_US
dc.identifier.citedreferenceRiemersma RA, Wood DA, Butler S. et al. Linoleic acid content in adipose tissue and coronary heart disease. Br Med J 1986; 292: 1423 – 7.en_US
dc.identifier.citedreferenceRiemersma RA, Oliver M., Elton RA et al. Plasma antioxidants and coronary heart disease: vitamins C and E and selenium. Eur J Clin Nutr 1990; 44: 143 – 50.en_US
dc.identifier.citedreferenceAnonymous. Vitamin E monograph. In: Olin BR, Hebel SK, Dombek CE et al, eds. Drug facts and comparisons. St. Louis: Facts and Comparisons, 1994: 5 – 5a.en_US
dc.identifier.citedreferenceBendich A., Machlin L. Safety of oral intake of vitamin E. Am J Clin Nutr 1988; 48: 612 – 19.en_US
dc.identifier.citedreferenceSitren HS. Vitamin E. In: Baumgartner TG ed. Clinical guide to parenteral micronutrition, 2nd ed. Fujisawa, Japan: USA Inc., 1991: 389 – 408.en_US
dc.identifier.citedreferenceMachlin LJ. Vitamin E. In: Machlin LJ ed. Handbook of vitamins, 2nd ed. New York: Marcel Dekker, 1991: 99 – 143.en_US
dc.identifier.citedreferenceMarks J. The safety of the vitamins: an overview. In: Walter P., Brubacher G., Stahelin H. eds. Elevated dosages of vitamins. Toronto: Hans Huber, 1989: 12 – 20.en_US
dc.identifier.citedreferenceHeinonen OP, Huttunen JK, Albanes D. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029 – 35.en_US
dc.identifier.citedreferenceGerster H. Potential role of β‐carotene in the prevention of cardiovascular disease. Int J Vitam Nutr Res 1991; 61: 277 – 91.en_US
dc.identifier.citedreferenceBurton GW, Ingold KU. β‐Carotene: an unusual type of lipid antioxidant. Science 1984; 224: 569 – 73.en_US
dc.identifier.citedreferenceQuintao E., Witztum JL, Parthasarathy S. et al. Role of β‐carotene in the oxidative modification of low density lipoproteins [abstr]. Arteriosclerosis 1989; 9: 758a.en_US
dc.identifier.citedreferenceManson JE, Stampfer MJ, Willet WC et al. A prospective study of anti‐oxidant vitamins and the incidence of coronary heart disease in women [abstr]. Circulation 1991; 84: 2168.en_US
dc.identifier.citedreferenceGaziano JM, Manson JE, Branch LG et al. Dietary beta‐carotene and decreased cardiovascular mortality in an elderly cohort [abstr], J Am Coll Cardiol 1992; 19: 377A.en_US
dc.identifier.citedreferenceGaziano JM, Manson JE, Redker PM et al. Beta‐carotene therapy for chronic stable angina [abstr]. Circulation 1992; 82: 202.en_US
dc.identifier.citedreferenceGoodwin TW. Mammals. In: Walworth T. ed. The biochemistry of the carotenoids. New York: Chapman & Hall, 1984: 173 – 95.en_US
dc.identifier.citedreferenceMicozzi MS, Brown ED, Taylor PR et al. Carotenodermia in men with elevated carotenoid intake from foods and β‐carotene supplements. Am J Clin Nutr 1988; 48: 1061 – 4.en_US
dc.identifier.citedreferenceAnonymous. Beta‐carotene monograph. In: Olin BR, Hebel SK, Dombek CE et al, eds. Drug facts and comparisons. St. Louis: Facts and Comparisons, 1994: 744.en_US
dc.identifier.citedreferenceBendich A. The safety of β‐carotene. Nutr Cancer 1988; 11: 207 – 14.en_US
dc.identifier.citedreferenceFrei B., Stocker R., Ames BN. Anti‐oxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A 1988; 85: 9748 – 52.en_US
dc.identifier.citedreferenceFrei B., Stocker R., England L. et al. Ascorbate: the most effective antioxidant in human blood plasma. In: Emerit I., Packer L. eds. Antioxidants in therapy and preventive medicine. London: Plenum Press, 1990: 155 – 63.en_US
dc.identifier.citedreferenceNiki E. Antioxidants in relation to lipid peroxidation. Chem Phys Lipids 1987; 44: 227 – 53.en_US
dc.identifier.citedreferenceSato K., Niki E., Shimasaki H. Free radical‐mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamins E and C. Arch Biochem Biophys 1990; 279: 402 – 5.en_US
dc.identifier.citedreferenceNiki E. Interaction of ascorbate and α‐tocopherol. Ann NY Acad Sci 1987; 498: 186 – 99.en_US
dc.identifier.citedreferenceNiki E., Yamamoto Y., Takahashi M. et al. Inhibition of oxidation of biomembranes by tocopherol. Ann NY Acad Sci 1989; 570: 23 – 31.en_US
dc.identifier.citedreferenceEnstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992; 3: 194 – 202.en_US
dc.identifier.citedreferenceManson JE, Meir J., Stampfer MJ et al. A prospective study of vitamin C and incidence of coronary heart disease in women [abstr]. Circulation 1992; 85: 865.en_US
dc.identifier.citedreferenceMelethil S., Subrahmayam MB, Chang J. et al. Megadoses of vitamin C: a pharmacokinetic evaluation. Ann NY Acad Sci 1987; 498: 491 – 3.en_US
dc.identifier.citedreferenceHodges RE. Vitamin C. In: Alfin‐Slater RB, Kritchevsky P. eds. Human nutrition: a comprehensive treatise. New York: Plenum Press, 1980: 73 – 96.en_US
dc.identifier.citedreferenceMoser U., Bendich A. Vitamin C. In: Machlin L. ed. Handbook of vitamins. New York: Marcel Dekker, 1991: 195 – 232.en_US
dc.identifier.citedreferenceKubler W., Gehler J. Kinetics of intestinal absorption of ascorbic acid: calculated non‐dosage‐dependent absorption processes. Int J Vitam Nutr Res 1970; 40: 442 – 53.en_US
dc.identifier.citedreferenceAnonymous. Vitamin C monograph. In: Olin BR, Hebel SK, Dombek CE et al, eds. Drug facts and comparisons. St. Louis: Facts and Comparisons, 1994: 10a‐c.en_US
dc.identifier.citedreferenceBalcke P., Schmidt P., Zaggornik J. et al. Ascorbic acid aggravates secondary hyperoxalemia in patients on chronic hemodialysis. Ann Intern Med 1984; 101: 344 – 5.en_US
dc.identifier.citedreferenceRivers JM. Safety of high‐level vitamin C ingestion. Ann NY Acad Sci 1987; 498: 225 – 54.en_US
dc.identifier.citedreferenceCochrane W. Overnutrition in prenatal and neonatal life: a problem. Can Med Assoc J 1965; 93: 893 – 9.en_US
dc.identifier.citedreferenceRhead WJ, Schranzer GN. Risk of long‐term ascorbic acid overdosage. Nutr Rev 1971; 29: 262 – 3.en_US
dc.identifier.citedreferenceRotruck JT, Pope AL, Ganther HE et al. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973; 179: 588.en_US
dc.identifier.citedreferenceAwasthi YC, Beutler CE, Srivastava SK. Purification and properties of human erythrocyte glutathione peroxidase. J Biol Chem 1975; 250: 5144.en_US
dc.identifier.citedreferenceMoore JA, Noiva R., Wells IC. Selenium concentrations in plasma of patients with arteriographically defined coronary atherosclerosis. Clin Chem 1984; 30: 1171 – 3.en_US
dc.identifier.citedreferenceSalonen JT, Alfthan G., Pikkarainen J. et al. Association between cardiovascular death and myocardial infarction and serum selenium in a matched‐pair longitudinal study. Lancet 1982; 2: 175 – 9.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1875-9114.1995.tb02875.x.pdf
Size:
1.218MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.